<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: Pacemaker and defibrillator <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> are an uncommon, but catastrophic complication of device implantation </plain></SENT>
<SENT sid="1" pm="."><plain>The present study examined the prevalence of device-related <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e>, the patterns of antibiotic resistance, and the presence of <z:chebi fb="0" ids="6827">methicillin</z:chebi> resistant staphylococcus aureus (MRSA) nares colonization in device implant recipients </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Two protocols were employed using a retrospective and a prospective analysis </plain></SENT>
<SENT sid="3" pm="."><plain>A retrospective chart review of 218 patients with suspected device <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> from 1/2000 to 1/2011 was performed </plain></SENT>
<SENT sid="4" pm="."><plain>Demographics, <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> rates, and patterns of antibiotic resistance were compared </plain></SENT>
<SENT sid="5" pm="."><plain>The prospective analysis enrolled one hundred eighty two patients undergoing device implantations or generator replacements </plain></SENT>
<SENT sid="6" pm="."><plain>The nares were swabbed and analyzed for the presence of staphylococcus aureus, and tested for <z:chebi fb="0" ids="6827">methicillin</z:chebi> sensitivity </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Over a period of ten years, 12,771 device implants/generator changes/system revisions were performed, with an <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> rate of 1.2% </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="0" ids="6827">Methicillin</z:chebi> resistance (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>) was identified in 98/218 (44.9%) of patients </plain></SENT>
<SENT sid="9" pm="."><plain>Those with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> had more <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>There was no significant increase in <z:chebi fb="0" ids="6827">methicillin</z:chebi> resistance over time (p=0.30) </plain></SENT>
<SENT sid="11" pm="."><plain>Our prospective analysis included 110 men </plain></SENT>
<SENT sid="12" pm="."><plain>A total of 32 patients (17.6%) had positive cultures for SA: 6.6% with MRSA </plain></SENT>
<SENT sid="13" pm="."><plain>Patients positive for MRSA nares colonization had a statistically significant greater length of hospital stay 8.5 days (mean) versus 4.4 days (P=0.049) </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSIONS: <z:chebi fb="0" ids="6827">Methicillin</z:chebi> resistant organisms appear to be emerging and persistent pathogens in device implants </plain></SENT>
<SENT sid="15" pm="."><plain>The screening of MRSA colonization may identify new populations at risk </plain></SENT>
<SENT sid="16" pm="."><plain>Further studies and analysis are needed to determine the cost effectiveness of a screening protocol </plain></SENT>
</text></document>